ADJUNCTIVE METHYLENE BLUE IN SEPTIC SHOCK (BLUSH): A PILOT RANDOMIZED CONTROLLED TRIAL

Registry ID

LHICU123

Source registry

HEALTH_CANADA

Status

Pending

Study type

INTERVENTIONAL

Sponsor

DR SHANNON MARIO FERNANDO

Last update

2024-12-17

Conditions

• SEPTIC SHOCK
• CRITICALLY ILL

Related clinical trials

• BETA-BLOCKER THERAPY VERSUS STANDARD CARE IN PATIENTS WITH SEPTIC SHOCK: A PILOT RANDOMIZED CONTROLLED TRIAL UTILIZING PREDICTIVE ENRICHMENT WITH POINT-OF-CARE ULTRASOUND
• KETAMINE SEDATION IN THE INTENSIVE CARE UNIT (KANINE): A PILOT RANDOMIZED CONTROLLED TRIAL
• NON-INVASIVE VENTILATION AND DEXMEDETOMIDINE IN CRITICALLY ILL ADULTS: A PRAGMATIC RANDOMIZED CONTROLLED TRIAL (INDEX TRIAL).
• UMBILICAL MESENCHYMAL STROMAL CELLS AS CELLULAR IMMUNOTHERAPY FOR SEPTIC SHOCK (UC-CISS II): A MULTI-CENTER, DOUBLE-BLIND, PHASE II RANDOMIZED CONTROLLED TRIAL
• A MULTI CENTER CONCEALED-ALLOCATION PARALLEL-GROUP BLINDED RANDOMIZED CONTROLLED TRIAL TO ASCERTAIN THE EFFECT OF MIDODRINE COMPARED TO PLACEBO ON INTRAVENOUS VASOPRESSOR DURATION AND ICU LENGTH OF STAY FOR CRITICALLY ILL PATIENTS
• PRAGMATIC PEDIATRIC TRIAL OF BALANCED VERSUS NORMAL SALINE FLUIDS IN SEPSIS (PROMPT BOLUS)

View on source registry